跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BORTEZOMIB GLENMARK 2,5 MG/ML SOLUCION INYECTABLE - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BORTEZOMIB GLENMARK 2,5 MG/ML SOLUCION INYECTABLE
Approved
STANDARD
BORTEZOMIB GLENMARK 2,5 MG/ML SOLUCION INYECTABLE
Glenmark Arzneimittel Gmbh
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 23, 2025
Approval ID
34ee21a557259c63
Company
Glenmark Arzneimittel Gmbh
Type
Standard
Approval Details
Approval Id
34ee21a557259c63
Drug Cima Aemps Name
BORTEZOMIB GLENMARK 2,5 MG/ML SOLUCION INYECTABLE
Register Number
90094
Holder Company Name
Glenmark Arzneimittel Gmbh
Marketing Company Name
Glenmark Farmaceutica S.L.U
Holder Company Detail Path
/organization/glenmark-arzneimittel-gmbh
Authorization Date
2025-01-23
Dosage Form
SOLUCIÓN INYECTABLE
Dose
2,5 mg/ml
Route Of Administration
VÍA INTRAVENOSA, VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Glenmark Arzneimittel Gmbh
Company Detail Path
/organization/glenmark-arzneimittel-gmbh
Company Information
Pharmaceutical Company Name
Glenmark Arzneimittel GmbH
Country Name
Germany
Website
http://www.glenmark.de
Active Ingredients
BORTEZOMIB
2,5 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 23, 2025
Approval ID
34ee21a557259c63
Type
Standard
Back to CIMA-AEMPS Approvals
